Spermosens has announced that Tore Duvold will assume the position of new CEO of the company as of 1 May 2024. He has held senior positions as SVP at LEO Pharma AS and as CEO of companies such as Edvince AB, Coegin Pharma AB, Innovation Fund Denmark, and Aker BioPharma AS. Ulrik Nilsson, the current interim CEO and CFO, will continue in his role as CFO.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.061 SEK | -1.29% | -4.69% | -91.22% |
30/05 | Spermosens AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
23/04 | Spermosens AB Appoints Tore Duvold as CEO, Effective May 1, 2024 | CI |
- Stock Market
- Equities
- SPERM Stock
- News Spermosens AB
- Spermosens AB Appoints Tore Duvold as CEO, Effective May 1, 2024